EGR2 and Alzheimer disease: Our study identified two potential biomarkers for pre-symptomatic AD in females: EGR2 and HIST1H2AA. In addition, we found that early (at 4-months) DZ/DIB-treatment induced the upregulation of some genes known to be downregulated in AD.